Author Correction: Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension

Affiliations

• ¹ National Heart and Lung Institute, Imperial College London, London, UK.
• ² University of Jeddah, College of Science, Department of Biology, Jeddah, Saudi Arabia.
• ³ Department of Physics, King's College London UK, London, UK.
• ⁴ Amsterdam UMC, VU University Medical Center, Department of Pulmonary Diseases, Amsterdam Cardiovascular Sciences (ACS), Amsterdam, The Netherlands.
• ⁵ Max Planck Institute for Heart and Lung Research, Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Bad Nauheim, Germany.
• ⁶ Department of Internal MedicineUniversities of Giessen and Marburg Lung Center (UGMLC), Member of the DZL, Justus Liebig University, Giessen, Germany.
• ⁷ National Center for Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.
• ⁸ Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
• ⁹ Centre for Pulmonary Hypertension, Thoraxclinic, Institute for Human Genetics, University of Heidelberg, Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.
• ¹⁰ Laboratory of Molecular Genetic Diagnostics, Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
• ¹¹ National Heart and Lung Institute, Imperial College London, London, UK. [email protected].